What are the recommended resting heart rate and heart‑rate variability targets for adults aged ≥ 45 years, and how should they be monitored and managed?

Resting Heart Rate and Heart Rate Variability Targets for Adults ≥45 Years

Resting Heart Rate Targets

For adults aged 45 and above, a normal resting heart rate ranges from 60-100 beats per minute, with lower values (50-60 bpm) acceptable in well-conditioned individuals, and no specific "target" exists beyond ensuring rates remain within physiologically normal bounds unless specific cardiac conditions require rate control. 1

Normal Ranges by Age

• Adults 45-65 years: Resting heart rate typically 60-80 bpm, with the second percentile ranging from 40-55 bpm depending on sex and age 1
• Older adults (>65 years): Similar ranges apply, though heart rate declines gradually with aging 2
• Bradycardia definition: Heart rate <50 bpm and/or sinus pauses >3 seconds warrant evaluation only if symptomatic 1

Clinical Context for Rate Control

Rate control targets apply primarily to specific arrhythmias, not healthy adults:

• Atrial fibrillation: Target <110 bpm at rest for most patients; stricter control (60-80 bpm) only if persistent symptoms or tachycardia-induced cardiomyopathy suspected 1, 3
• Exercise response: During moderate exercise, target 90-115 bpm; age-predicted maximum heart rate calculated as 220 - age, though considerable variability (±10-15 bpm) exists 1, 4

Important Caveats

• Asymptomatic bradycardia or sinus pauses alone should not trigger treatment; symptoms are the primary indication for intervention 1
• Medications (beta-blockers, calcium channel blockers, digoxin) significantly alter normal ranges and must be considered when interpreting heart rate 1
• Chronotropic incompetence (failure to reach 80% of heart rate reserve during exercise) requires individualized assessment and cannot be determined by age alone 1

---

Heart Rate Variability (HRV) Targets

There are no established "target" HRV values for clinical management in adults ≥45 years; rather, HRV serves as a prognostic marker where lower values indicate increased cardiovascular risk and mortality, with age-related decline being physiologically normal. 2, 5

Normal Age-Related Decline

HRV decreases progressively with aging in healthy adults, with the pattern varying by measurement method:

• SDNN (standard deviation of all RR intervals): Decreases gradually to 60% of young adult baseline by age 90 2
• SDNN index: Linear decline reaching 46% of baseline by age 90 2
• rMSSD and pNN50 (vagal modulation markers): Most rapid decline, reaching 47% and 24% of baseline respectively by age 60, then stabilizing 2
• Short-term HRV (5-minute recordings): Marked reduction in ages 25-54, with relative constancy after age 55 6

Gender Differences

• Before age 50: Women have lower HRV than men across all measures 2
• After age 50: Gender differences disappear 2

Clinical Significance

Lower HRV independently predicts functional decline and mortality in older adults:

• Functional decline risk: Lowest tertile of SDNN (1.70-13.30 ms) associated with 1.21-fold higher risk of ADL decline and 1.25-fold higher risk of IADL decline, independent of cardiovascular disease 5
• Higher resting heart rate (>71 bpm) associated with 1.79-fold higher risk of ADL decline 5

Measurement Considerations

For clinical or research assessment of HRV in adults ≥45:

• Recording duration: 5-10 minutes of rest provides substantial to excellent reproducibility (ICC >0.6) 7, 8
• Body position: Supine position yields highest HRV values; standing reduces HRV by approximately 10-15 bpm equivalent 7
• Controlled conditions required: Stable respiratory frequency, no recent caffeine/alcohol, validated recording device with proper artifact correction 8
• Time-domain measures (SDNN, rMSSD) demonstrate greater reproducibility than frequency-domain parameters 7

Critical Limitation

In adults >65 years, HRV of healthy subjects may fall below published mortality risk cutpoints (25% using SDNN index, 12% using rMSSD, 4% using pNN50), limiting the predictive value of HRV in elderly populations. 2

---

Monitoring Approach

Routine monitoring of resting heart rate and HRV is not recommended for asymptomatic adults ≥45 years without cardiovascular disease. 1, 5

When to Monitor Heart Rate:

• Symptomatic bradycardia or tachycardia: 24-hour Holter monitoring to assess rate patterns and pauses 1, 3
• Atrial fibrillation: Resting heart rate measurement plus 24-hour Holter or exercise testing to assess rate control adequacy 1, 3
• Exercise intolerance: Exercise testing to evaluate chronotropic response and exclude rate-related ischemia 1

When to Monitor HRV:

• Research or risk stratification contexts only: HRV assessment may identify high-risk individuals for cardiovascular events or functional decline, but no therapeutic interventions are established based on HRV values alone 5, 8